AzTrials
AzTrials

Dysarthria As Late Effect of StrokeNCT04427670

Group Intervention Study for Individuals with Dysarthria Following Stroke and Their Carers in Pakistan

A study testing Group intervention and Regular speech therapy in people with Dysarthria As Late Effect of Stroke, run by Isra University at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Dysarthria is a common problem in Pakistan. therefore the current study aims to translate the dysarthria communication tools into urdu language for better understanding the population and the problem Read more about this study

Who is it for?
Ages 40 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Dysarthria As Late Effect of Stroke
What is being tested?
Group intervention and Regular speech therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePakistan
Study dates
1 Dec 2020to 12 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 40 to 70 years age ranges
  • History of dysarthria previous six monthes
  • Primary level of education
  • Functional hearing and visual ablities -

Who cannot join

  • Patient with age below 40 to 70
  • Patients with diagnosis severe psychological illness
  • Patient with developmental dysarthria
  • Patient who come alone without any attendent

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Sheikh Zayed medical Complex

    Lahore, Punjab Province, 54000

Other trials in Pakistan

About this study

Official title: Implementation and Feasibility Study of Group Intervention for Individuals with Dysarthria Following Stroke and Their Carers in Pakistan

Dysarthria is a common problem in Pakistan. therefore the current study aims to translate the dysarthria communication tools into urdu language for better understanding the population and the problem

Read the detailed description

Dysarthria is the inefficiency or restricted capability to form intelligible speech because of the inability of motor control on the speech structures. There are many therapeutic approaches in Pakistan that are in use for the patients with dysarthria following stroke. One of them is one to one intervention which may include one dysarthria client along with the speech therapist. The therapist delivers step by step instructions to the client. The essential assessments are being held to initiate the treatment. The application of this intervention approach leaves some drawbacks, such as, the patients find it difficult to relate and adapt to the treatment offered. Generalization also seems to be complicated. The patients express a lack in motivation and support. The other mode of approach is group intervention, in which multiple dysarthria clients along with their caregivers \& speech therapist are included. In the later one, there are greater chances of recovery for patients as they get peer support and build confidence through newfound friends, peer communication with realistic social setting, learning through teaching, increased awareness of skills and it is time constraints. The culture of practicing group sessions with dysarthria patients is lacked in Pakistan, which intends to meet and compensate for all the drawbacks and lacks of one on one intervention. By including the Dysarthria patients, therapist and the caregivers in the group intervention, there're greater chances of reduced anxiety for both patients \& caregivers regarding disorder \& its recovery.

Being tested
Group intervention, Regular speech therapy
Keywords
Stroke, Dysarthia, Intervention
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Group interventionOther

    Group intervention programme designed for stroke survivors with dysarthria and their carers. The programme was eight weeks long, with weekly two sessions, each session lasting for two hours, lead by speech language therapist and was comprised of activities which addressed participants education about their dysarthria and stroke. The role of family , peer and professional was to provide support and communication practice.

  • Regular speech therapyOther

    Regular speech therapy will be provided to the controlled group.Regular speech therapy is one to one speech therapy session,conducted twice a week for the duration of eight weeks.This intervention is implemented to patients with dysarthria following stroke in a format of one patient and one therapist per session.

Study groups in NCT04427670
Study groupRoleWhat they receive
Regular speech therapyOtherRegular speech therapy will be provided to the controlled group.
Receives: Other: Regular speech therapy
Group interventionOtherGroup intervention will be provided to the experimental group.
Receives: Other: Group intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. efficacy of group intervention for Patients With Dysarthria will be assessed by the translated version of Roberston Dysarthria Profile.

    Roberston Dysarthria Profile take responses on 5 point likert scale where 1 for worst and 5 for better outcome.

    Measured: 6 months

  2. efficacy of group intervention for Patients With Dysarthria will be assessed by translated version of Communication Effectivness Measure

    Communication Effectivness Measure is seven point scale arranging from 1 to 7 where 1 for worst outcome and 7 for better outcome.

    Measured: 6 months

  3. Efficacy of group intervention for Patients With Dysarthria will be assessed by the translated version of Communicative Participation Item Bank.

    Communicative Participation Item Bank is four point scale arranging from 0 to 3 where 0 for better communication participation and 3 for worst communication participation.

    Measured: 6 months

  4. Efficacy of group intervention for Patients With Dysarthria will be assessed by Gernal Health Questionnaire

    Gernal Health Questionnaire is four point scale in which responses 1 means better and 4 for worst condition

    Measured: 6 months

  5. Efficacy of group intervention for Patients With Dysarthria will be assessed by Speech Intelligiblity Test

    Speech Intelligiblity Test is three point scale where 2 stands for correct utterances and 0 shows wrong production of sounds.

    Measured: 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2020
  2. Study start1 Dec 2020
  3. Primary completion15 Nov 2021
  4. Study completion12 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
RCT with intervention having experimental group. random Allocation of participants.
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04427670
Sponsor's protocol ID
201/2020
Status last verified
Oct 2024
First submitted
14 Mar 2020
Last updated
15 Oct 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Group intervention and Regular speech therapy in people with Dysarthria As Late Effect of Stroke, run by Isra University at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

efficacy of group intervention for Patients With Dysarthria will be assessed by the translated version of Roberston Dysarthria Profile. (time frame: 6 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in